Which medications in the drug class PI3K Inhibitors are used in the treatment of Breast Cancer?

Updated: Feb 04, 2021
  • Author: Pavani Chalasani, MD, MPH; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print

PI3K Inhibitors

Alpelisib (Piqray)

PI3K inhibitor indicated in combination with fulvestrant for treatment of men and postmenopausal women with HR+/HER2-, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!